PT  - JOURNAL ARTICLE
AU  - Bates, Timothy A.
AU  - Leier, Hans C.
AU  - McBride, Savannah K.
AU  - Schoen, Devin
AU  - Lyski, Zoe L.
AU  - Lee, David X.
AU  - Messer, William B.
AU  - Curlin, Marcel E.
AU  - Tafesse, Fikadu G.
TI  - The time between vaccination and infection impacts immunity against SARS-CoV-2 variants
AID  - 10.1101/2023.01.02.23284120
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.01.02.23284120
4099  - http://medrxiv.org/content/early/2023/01/04/2023.01.02.23284120.short
4100  - http://medrxiv.org/content/early/2023/01/04/2023.01.02.23284120.full
AB  - As the COVID-19 pandemic continues, long-term immunity against SARS-CoV-2 will be globally important. Official weekly cases have not dropped below 2 million since September of 2020, and continued emergence of novel variants have created a moving target for our immune systems and public health alike. The temporal aspects of COVID-19 immunity, particularly from repeated vaccination and infection, are less well understood than short-term vaccine efficacy. In this study, we explore the impact of combined vaccination and infection, also known as hybrid immunity, and the timing thereof on the quality and quantity of antibodies produced by a cohort of 96 health care workers. We find robust neutralizing antibody responses among those with hybrid immunity against all variants, including Omicron BA.2, and we further found significantly improved neutralizing titers with longer vaccine-infection intervals up to 400 days. These results indicate that anti-SARS-CoV-2 antibody responses undergo continual maturation following primary exposure by either vaccination or infection for at least 400 days after last antigen exposure. We show that neutralizing antibody responses improved upon secondary boosting with greater impact seen after extended intervals. Our findings may also extend to booster vaccine doses, a critical consideration in future vaccine campaign strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by a grant from the M. J. Murdock Charitable Trust (to MEC), an unrestricted grant from the OHSU Foundation (to MEC), the NIH training grant T32HL083808 (to TAB), NIH grant R011R01AI141549-01A1 (to FGT), OHSU Innovative IDEA grant 1018784 (to FGT), and NIH grant R01AI145835 (to WBM). We thank the participants of this study for their contribution. We additionally thank the OHSU COVID-19 serology study team and the OHSU department of Occupational Health for recruiting participants and collecting samples, and the OHSU clinical laboratory under the direction of D. Hansel and X. Qin for SARS-CoV-2 testing and reporting. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Oregon Health and Sciences University Institutional review board gave ethical approval for this work (IRB#00022511).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors